Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cancers
|
July 13, 2024
Advancements in First-Line Treatment of Metastatic Bladder Cancer: EV-302 and Checkmate-901 Insights and Future Directions
Vijay Kumar Srinivasalu, Debbie Robbrecht
Cancers
|
July 29, 2023
Immunotherapy in Urothelial Cancer: Stop When Achieving a Response, Restart upon Disease Progression
Youssra Salhi, Ronald De Wit, Debbie Robbrecht
Nederlands Tijdschrift Voor Geneeskunde
|
July 18, 2013
[Symptomatic hypocalcaemia on denosumab use]
Vania Baptista Lopes, Debbie Robbrecht, Sjoerd van Thiel, et al.
Cancer Treatment and Research Communications
|
April 18, 2025
Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045
Anke Richters, Britt Suelmann, Mira Franken, et al.
Cancers
|
April 3, 2021
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study
Nicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, et al.
European Urology Oncology
|
April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 Trials
Charles Vauchier, Constance Thibault, Maud Velev, et al.
British Journal of Cancer
|
December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
Debbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.
British Journal of Cancer
|
May 23, 2022
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing
Melinda A Pruis, Floris H Groenendijk, K Sangeeta Badloe, et al.
Critical Reviews in Oncology/Hematology
|
November 26, 2022
International consensus on the initial diagnostic workup of cancer of unknown primary
Iris van der Strate, Fatemeh Kazemzadeh, Iris D Nagtegaal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
Neeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cancers
|
July 13, 2024
Advancements in First-Line Treatment of Metastatic Bladder Cancer: EV-302 and Checkmate-901 Insights and Future Directions
Vijay Kumar Srinivasalu, Debbie Robbrecht
Cancers
|
July 29, 2023
Immunotherapy in Urothelial Cancer: Stop When Achieving a Response, Restart upon Disease Progression
Youssra Salhi, Ronald De Wit, Debbie Robbrecht
Nederlands Tijdschrift Voor Geneeskunde
|
July 18, 2013
[Symptomatic hypocalcaemia on denosumab use]
Vania Baptista Lopes, Debbie Robbrecht, Sjoerd van Thiel, et al.
Cancer Treatment and Research Communications
|
April 18, 2025
Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045
Anke Richters, Britt Suelmann, Mira Franken, et al.
Cancers
|
April 3, 2021
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study
Nicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, et al.
European Urology Oncology
|
April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 Trials
Charles Vauchier, Constance Thibault, Maud Velev, et al.
British Journal of Cancer
|
December 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
Debbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, et al.
British Journal of Cancer
|
May 23, 2022
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing
Melinda A Pruis, Floris H Groenendijk, K Sangeeta Badloe, et al.
Critical Reviews in Oncology/Hematology
|
November 26, 2022
International consensus on the initial diagnostic workup of cancer of unknown primary
Iris van der Strate, Fatemeh Kazemzadeh, Iris D Nagtegaal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2024
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
Neeltje Steeghs, Carlos Gomez-Roca, Kristoffer S Rohrberg, et al.
Page
of 2